Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening (BENEFIT-C)

Tulane University

Status: Completed

Conditions: COVID-19; Vaccine-Preventable Diseases; Influenza; Vaccine Hesitancy; Healthcare Patient Acceptance; Health Behavior; Colorectal Cancer

Treatments: Behavioral: Financial incentive for colorectal cancer screening; Behavioral: Financial incentive for COVID-19 shot; Behavioral: Financial incentive for flu shot

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06124131

2020-1600-BENC

OT2HL158287 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:

• Do patient financial incentives for completing colorectal cancer screening increase screening completion?
• Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?

Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.

Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Enrollment: 50 patients

Sex: All

Ages: 45 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 45 to 75
• Receive care at participating primary care clinic
• Due for colorectal cancer screening
• Ability to understand and speak English

Exclusion criteria

• Currently participating in another clinical trial or research study on colorectal cancer screening
• Unable or unwilling to give informed consent

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

50 participants in 2 patient groups

Full financial incentives

Experimental group

Description:

$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening

Treatment:

Behavioral: Financial incentive for COVID-19 shot

Behavioral: Financial incentive for flu shot

Behavioral: Financial incentive for colorectal cancer screening

Partial financial incentives

Active Comparator group

Description:

$50/service patient financial incentive for completion of: COVID-19 shot, flu shot

Treatment:

Behavioral: Financial incentive for COVID-19 shot

Behavioral: Financial incentive for flu shot